CD8A and hepatocellular carcinoma: To investigate whether TPX2 overexpression could improve the antitumor activity of TIL-CD8+ T cells, we isolated CD8+ T cells from fresh HCC tissues, which were then treated with LV-NC as a control or LV-TPX2 for TPX2 overexpression (Supplementary Fig. S4).